Articles by Luke Timmerman



Cancer Drug Spurned in U.S. Approved

  • 09 April 08
  • Bloomberg
Antigenics, the maker of a drug that stimulates the immune system against kidney cancer, won approval to market the product in Russia after a study failed to meet the statistical standard in the United States.